Literature DB >> 28349448

Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.

Kosei Hasegawa1, Hiroyuki Tanaka2,3, Miho Yamashita2, Yousuke Higuchi2, Takayuki Miyai2, Junko Yoshimoto2, Ayumi Okada2, Norihiro Suzuki4, Keiji Iwatsuki4, Hirokazu Tsukahara2.   

Abstract

Genetic mutation of the coproporphyrinogen oxidase (CPOX) gene causes either hereditary coproporphyria (HCP) or harderoporphyria. HCP, a rare hepatic porphyria, causes acute attacks after puberty and rarely accompanies cutaneous symptoms. In contrast, harderoporphyria is an erythropoietic porphyria that represents photosensitivity and hemolytic anemia from the neonatal period. In patients with harderoporphyria, the p.Lys404Glu mutation is found in the homozygous or compound heterozygous state with another mutation, and a marked increase in harderoporphyrin is observed. This report describes a neonate with symptoms of erythropoietic harderoporphyria (photosensitivity of the skin, hemolytic anemia, and jaundice). However, the pattern of porphyrin metabolites of feces was consistent with that of typical HCP, not of harderoporphyria. We found a heterozygous, novel, four-base pair deletion in exon 7 of the CPOX gene, although other mutations including the p.Lys404Glu mutation in CPOX were not found. By unknown etiology, our patient had accompanying adrenocortical insufficiency and 46, XY disorders of sex development. Based on genetic mutation of the CPOX gene and information from a previous similar case report, we consider that neonatal-onset HCP is a variant of HCP.

Entities:  

Keywords:  Coproporphyrinogen oxidase; Hereditary coproporphyria; Jaundice; Neonate; Photosensitivity

Year:  2017        PMID: 28349448      PMCID: PMC5740044          DOI: 10.1007/8904_2017_20

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  16 in total

1.  Neonatal-onset hereditary coproporphyria with male pseudohermaphrodism.

Authors:  H Takeuchi; M Kondo; M Daimon; S Susa; K Ueoka; O Uemura; H Togari
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

2.  Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria.

Authors:  Caroline Schmitt; Laurent Gouya; Eva Malonova; Jérôme Lamoril; Jean-Michel Camadro; Magali Flamme; Christian Rose; Said Lyoumi; Vasco Da Silva; Catherine Boileau; Bernard Grandchamp; Carole Beaumont; Jean-Charles Deybach; Hervé Puy
Journal:  Hum Mol Genet       Date:  2005-09-13       Impact factor: 6.150

Review 3.  Porphyrias.

Authors:  Raili Kauppinen
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria.

Authors:  J Lamoril; P Martasek; J C Deybach; V Da Silva; B Grandchamp; Y Nordmann
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

5.  Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria.

Authors:  B Grandchamp; Y Nordmann
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

6.  Harderoporphyria: a variant hereditary coproporphyria.

Authors:  Y Nordmann; B Grandchamp; H de Verneuil; L Phung; B Cartigny; G Fontaine
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

7.  Homozygous case of hereditary coproporphyria.

Authors:  B Grandchamp; N Phung; Y Nordmann
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

8.  Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients.

Authors:  A Kühnel; U Gross; M O Doss
Journal:  Clin Biochem       Date:  2000-08       Impact factor: 3.281

9.  Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms.

Authors:  P Martasek; Y Nordmann; B Grandchamp
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

10.  Coproporphyrinogen oxidase: gene organization and description of a mutation leading to exon 6 skipping.

Authors:  M H Delfau-Larue; P Martasek; B Grandchamp
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.